AACR Special Conference in Cancer Research: Fusion-Positive Cancers

  13 Jan 2026 - 15 Jan 2026

   Philadelphia, Pennsylvania

conference-img

AACR Special Conference in Cancer Research: Fusion-Positive Cancers

13 Jan 2026

 - 

15 Jan 2026

Philadelphia, Pennsylvania



Hosted by the American Association for Cancer Research (AACR), the AACR Special Conference on Fusion-Positive Cancers 2026 will bring together leading researchers, clinicians, and translational scientists to discuss the latest advances in fusion oncogene biology, carcinogenesis, and targeted therapeutic strategies.

This premier event will explore the genetic and molecular mechanisms driving fusion-driven malignancies, highlighting key topics such as tumor modeling, condensate biology, gene regulatory networks, and novel therapeutic approaches.

International Conference on Positive Psychology and Mental Health

On: 05 Mar 2026

-

05 Mar 2026


International Conference on Health Psychology and Mental Health

On: 05 Mar 2026

-

06 Mar 2026


International Conference on Medical, Medicine and Health Sciences

On: 05 Mar 2026

-

06 Mar 2026


Annual Miami Breast Cancer Conference

On: 05 Mar 2026

-

08 Mar 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 05 Mar 2026

-

05 Mar 2026


International Conference on Positive Psychology and Mental Health

On: 05 Mar 2026

-

05 Mar 2026


International Conference on Health Psychology and Mental Health

On: 05 Mar 2026

-

06 Mar 2026


International Conference on Medical, Medicine and Health Sciences

On: 05 Mar 2026

-

06 Mar 2026


Annual Miami Breast Cancer Conference

On: 05 Mar 2026

-

08 Mar 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 05 Mar 2026

-

05 Mar 2026



Whats more on Hidoc Dr.


Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Scholastic performance is a key concern for young cancer patients, study finds

2.

Top FDA Official Exits; SCOTUS Takes Up Obamacare Case; Texas Doc Suspended

3.

Investigating the Relationship Between GERD and Anxiety/Depression.

4.

Through Consolidation Durvalumab, Limited-Stage SCLC Receives a New Standard of Care.

5.

In Biochemically Recurrent Nonmetastatic Prostate Cancer, Apalutamide Presents Its Argument.

Recommended News For You

Conferences That Might Interest You

Recommended Articles For You

Boost Your Knowledge With These Quizzes





© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot